Test Price
800 AED✅ Home Collection Available
Lyme Disease (Borrelia burgdorferi) Antibodies IgG & IgM Test in UAE | 800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing at DNA Labs UAE.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM) for serum samples.
- Clinical Guidance: Post-test telephonic interpretation with DHA-licensed physician Dr. Ajay Singh (DHA 36234132).
- Insurance & Billing: Direct billing verification via WhatsApp +971 54 548 8731; pre‑approvals handled for major UAE insurers.
Test Overview & Methodology
The Lyme Disease IgG & IgM Antibody test detects antibodies against Borrelia burgdorferi using a quantitative enzyme immunoassay (ELISA/EIA). This serological assay is recommended for individuals with suspected tick exposure, erythema migrans rash, or symptoms consistent with early disseminated or late‑stage Lyme borreliosis. Results must be interpreted alongside clinical presentation and exposure history.
| Feature | Our Test (ELISA/EIA) | Closest Alternative (Western Blot) |
|---|---|---|
| Methodology | Enzyme Immunoassay (quantitative) | Immunoblot (qualitative, confirmatory) |
| Turnaround Time | Next day (sample by Fri 6 PM) | 3–7 business days |
| Sensitivity | >95% (combined IgG/IgM) | Lower sensitivity in early disease |
| Clinical Utility | Screening & monitoring, quantitative titer | Confirmation only (no titration) |
Physician Insight & Safety Protocols
Clinical Correlation Note from Dr. Ajay Singh, DHA License 36234132: “I understand that waiting for Lyme test results can evoke anxiety. This assay provides highly reliable serological data, but a definitive diagnosis requires careful integration of your symptoms, tick‑exposure history, and clinical examination findings. Please do not rely on laboratory values alone; always meet your healthcare provider for a comprehensive interpretation.”
Advisory Notice
Medication Continuity
Do not discontinue any prescribed antibiotic therapy without consulting your doctor. Serological testing is not a substitute for ongoing clinical management of Lyme disease.
Exclusion Criteria & Emergency Red Flags
When to Avoid This Test
- Exclusion: Asymptomatic individuals with no documented tick exposure in non‑endemic regions should not be tested. This assay is not solely for monitoring treatment response; clinical scoring and follow‑up serologies are required.
- Emergency Red Flags: Seek immediate medical attention if you develop sudden facial droop (Bell’s palsy), severe headache with neck stiffness, irregular heartbeats, fainting, or sharp radiating nerve pain. These may indicate neuroborreliosis or Lyme carditis.
- Do not draw blood from an arm with known cellulitis or active rash at the puncture site.
Patient FAQ & Clinical Guidance
1. What does a positive Lyme IgG or IgM result mean?
A positive IgM suggests recent infection (within 2‑4 weeks), while a positive IgG typically indicates past or chronic Lyme exposure. However, cross‑reactive antibodies from other spirochetal infections can cause false positives; therefore, repeat testing or immunoblot confirmation is advised in borderline cases.
2. Do I need to fast or prepare specially for this test?
No fasting or special preparation is required; a standard serum sample collected in an SST tube is sufficient. We do recommend staying hydrated and informing the phlebotomist of any recent antibiotic use, as this may influence the immune response.
3. Can this test differentiate between active and past infection?
The combination of IgM and IgG titers, together with clinical symptoms and exposure history, helps distinguish active from past infection. In ambiguous cases, paired acute and convalescent sera drawn 2‑4 weeks apart may be necessary to demonstrate a rising antibody response indicative of active borreliosis.
UAE Regulatory & Data Privacy Adherence
This clinical service strictly abides by the following UAE legal frameworks:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring secure handling of patient information.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing electronic health records and telemedicine.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – safeguarding patient consent and clinical safety.
DNA Labs UAE operates under DHA Facility License No. 1143 and is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Lyme Disease (Borrelia burgdorferi) Antibodies IgG & IgM, Serum |
| Price (AED) | 800 |
| Turnaround Time | Next day (samples received by Friday 6 PM) |
| Sample Type / Matrix | Serum (2 mL, minimum 1 mL in SST tube) |
| Methodology Used | Quantitative Enzyme Immunoassay (ELISA/EIA) |
| ICD-10-CM Code | A69.2 (Lyme disease) |
| LOINC Code | 53806-2 (Borrelia burgdorferi Ab.IgG+IgM [Interpretation] in Serum) |
| DHA Facility License & Laboratory Address | DHA License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians